Why is Indrayani Biotec falling/rising?

As of 03-Jul, Indrayani Biotech Ltd's stock price is currently at 15.91, reflecting an increase of 0.43 or 2.78%. The stock has been on a positive trajectory, gaining for the last five days with a notable return of 14.54% during this period. However, despite this recent uptick, the stock has significantly underperformed over the longer term, with a year-to-date decline of 56.27% and a staggering 73.15% drop over the past year. The company's financial health is concerning, as it has reported operating losses and a high Debt to EBITDA ratio of 9.25 times, indicating a weak ability to service its debt. Additionally, the stock is trading at a discount compared to its peers, but its profits have plummeted by 134.9%, which raises red flags for potential investors.
In the broader market context, while Indrayani Biotech's stock has shown a positive short-term return, the benchmark Sensex has experienced a slight decline of 0.62% over the same one-week period. This contrast highlights the stock's recent gains against a backdrop of broader market weakness. However, the stock's long-term performance remains troubling, as it has underperformed the Sensex over the past year and three years. Furthermore, the falling participation from institutional investors, who have reduced their stake in the company, suggests a lack of confidence in its future prospects, which could further impact its stock price negatively.